D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$3.68B |
| 2 |
Boeing
BA
|
+$959M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$875M |
| 4 |
Tesla
TSLA
|
+$835M |
| 5 |
Eli Lilly
LLY
|
+$643M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$939M |
| 2 |
Palantir
PLTR
|
+$668M |
| 3 |
Apple
AAPL
|
+$644M |
| 4 |
Workday
WDAY
|
+$525M |
| 5 |
Spotify
SPOT
|
+$451M |
Sector Composition
| 1 | Technology | 20.55% |
| 2 | Consumer Discretionary | 13.27% |
| 3 | Healthcare | 12.29% |
| 4 | Financials | 8.39% |
| 5 | Industrials | 7.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CAPN
1976
Cayson Acquisition Corp Ordinary shares
CAPN
$81.6M
| $1.01M | ﹤0.01% |
+100,000
| New | +$1.01M |
|
1977
iShares Russell 2000 Growth ETF
IWO
$12.6B
| $1.01M | ﹤0.01% |
3,496
-14,646
| -81% | -$4.22M |
|
1978
Terex
TEX
$3.46B
| $998K | ﹤0.01% |
21,593
-43,259
| -67% | -$2M |
|
1979
Akero Therapeutics
AKRO
$3.48B
| $996K | ﹤0.01% |
35,809
-80,573
| -69% | -$2.24M |
|
|
CIM
1980
Chimera Investment
CIM
$1.15B
| $993K | ﹤0.01% |
70,902
-144,787
| -67% | -$2.03M |
|
1981
Lennox International
LII
$19.1B
| $987K | ﹤0.01% |
1,620
-473
| -23% | -$288K |
|
|
ENFN
1982
DELISTED
Enfusion, Inc.
ENFN
| $986K | ﹤0.01% |
95,697
+65,475
| +217% | +$674K |
|
1983
ATS Corp
ATS
$2.63B
| $985K | ﹤0.01% |
32,300
-38,289
| -54% | -$1.17M |
|
1984
Aaon
AAON
$6.7B
| $983K | ﹤0.01% |
8,352
-15,387
| -65% | -$1.81M |
|
1985
ORIX
IX
$30B
| $976K | ﹤0.01% |
45,915
+34,890
| +316% | +$741K |
|
1986
Luminar Technologies
LAZR
$129M
| $971K | ﹤0.01% |
180,475
+60,780
| +51% | +$327K |
|
1987
Lifeway Foods
LWAY
$509M
| $965K | ﹤0.01% |
38,897
-57,545
| -60% | -$1.43M |
|
1988
Yeti Holdings
YETI
$2.88B
| $964K | ﹤0.01% |
25,029
+12,285
| +96% | +$473K |
|
1989
iShares MSCI Australia ETF
EWA
$1.55B
| $956K | ﹤0.01% |
+40,053
| New | +$956K |
|
|
SVM
1990
Silvercorp Metals
SVM
$1.15B
| $955K | ﹤0.01% |
318,000
-122,400
| -28% | -$368K |
|
1991
PureCycle Technologies
PCT
$2.4B
| $953K | ﹤0.01% |
92,989
-101,885
| -52% | -$1.04M |
|
1992
Kontoor Brands
KTB
$4.5B
| $948K | ﹤0.01% |
11,100
-18,990
| -63% | -$1.62M |
|
1993
Capital Group Global Growth Equity ETF
CGGO
$7.05B
| $947K | ﹤0.01% |
32,413
+21,283
| +191% | +$622K |
|
1994
Monro
MNRO
$519M
| $945K | ﹤0.01% |
38,109
-160,344
| -81% | -$3.98M |
|
1995
BARK
BARK
$150M
| $942K | ﹤0.01% |
511,746
+428,719
| +516% | +$789K |
|
1996
Aldeyra Therapeutics
ALDX
$324M
| $941K | ﹤0.01% |
188,583
-146,198
| -44% | -$730K |
|
1997
FTAI Aviation
FTAI
$17.6B
| $930K | ﹤0.01% |
+6,460
| New | +$930K |
|
1998
Funko
FNKO
$182M
| $930K | ﹤0.01% |
69,464
+54,081
| +352% | +$724K |
|
1999
Select Medical
SEM
$1.55B
| $930K | ﹤0.01% |
49,330
-37,644
| -43% | -$710K |
|
2000
Erasca
ERAS
$443M
| $927K | ﹤0.01% |
369,254
-114,572
| -24% | -$288K |
|